Trilogy asked to explain 50c jump in share price in four days
The value of shares in Trilogy has risen from a market low of $3.50 on May 13 to a high of $4.00 at 13:26 on May 18.
Trilogy International [NZX:TIL], the skincare and home fragrance company, says it continues to comply with its market obligations after being asked to explain a 50c rise in its share price in four days of trading.
The value of shares in Trilogy has risen from a market low of $3.50 on May 13 to a high of $4.00 at 13:26 on May 18, an increase of 14.3%. That sparked a letter from the NZX asking whether the company is continuing to comply with the rules requiring the disclosure of information material to the share price.
In a response, Trilogy's chief financial officer Lindsay Render said that the company "continues to comply with its continuous disclosure obligations."
Trilogy bought the New Zealand cosmetics and fragrance distribution business, CS Company, last August. In March, it said sales for the full-year to the end of March were expected to exceed $83 million, with profit before tax above $13 million, ahead of analysts' expectations.
The company sells through the Trilogy, Ecoya and Goodness brands.
The shares have more than quadrupled in value since July 2015 when they traded at 91c. A short while ago they were trading at $3.95.
(BusinessDesk)
Edwin Mitson
Wed, 18 May 2016
Wed, 18 May 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Trilogy asked to explain 50c jump in share price in four days
58278